|Transcriptional regulatory networks underlying gene expression changes in Huntington's disease|
SA Ament, JR Pearl, JP Cantle, RM Bragg, PJ Skene, SR Coffey, ...
Molecular systems biology 14 (3), 2018
|Motivational, proteostatic and transcriptional deficits precede synapse loss, gliosis and neurodegeneration in the B6.Htt/+Q111/+ model of Huntington’s disease|
RM Bragg, SR Coffey, RM Weston, SA Ament, JP Cantle, S Minnig, ...
Scientific reports 7, 41570, 2017
|Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6. HttQ111/+ mouse model of Huntington’s disease|
SR Coffey, RM Bragg, S Minnig, SA Ament, JP Cantle, A Glickenhaus, ...
PloS one 12 (4), e0175968, 2017
|Genome-scale transcriptional regulatory network models for the mouse and human striatum predict roles for SMAD3 and other transcription factors in Huntington's disease|
SA Ament, JR Pearl, R Bragg, PJ Skene, S Coffey, DE Bergey, C Plaisier, ...
bioRxiv, 087114, 2016
|Early detection of apathetic phenotypes in Huntington’s disease knock-in mice using open source tools|
S Minnig, RM Bragg, HS Tiwana, WT Solem, WS Hovander, EMS Vik, ...
Scientific reports 8 (1), 2304, 2018